The benefits of ACE inhibitor therapy in myocardial infarction were primarily demonstrated by the SMILE trial, in which administration of zofenopril within 24 h of the onset of the myocardial infarction resulted in a significant reduction in mortality after 6 weeks of treatment, which was maintained or increased after one year of treatment [42]. Here, ACE is linked to myocardial infarction.